Multidisciplinary Research in Vulvodynia (R21 Clinical Trial Optional) | PA 18 096

Opportunity Information: Apply for PA 18 096

The National Institutes of Health (NIH) released this discretionary grant opportunity, titled "Multidisciplinary Research in Vulvodynia (R21 Clinical Trial Optional)," to stimulate new, exploratory research focused on vulvodynia, broadly described here as chronic vulvar pain with no clearly known cause. The announcement signals NIH's continued interest in treating vulvodynia as a priority research area and aims to bring more scientific attention to gaps in what causes the condition, how it can be prevented, how it should be diagnosed, and how it can be treated. A central theme of the opportunity is that progress in vulvodynia is likely to come from multidisciplinary approaches, meaning applications are encouraged to combine perspectives and methods across fields and to build interdisciplinary research teams rather than relying on a single specialty.

The FOA uses the R21 mechanism, which typically supports early-stage, high-impact, and often higher-risk projects designed to generate preliminary data, test novel ideas, or launch new research directions that could later be expanded into larger studies. In practical terms, this makes the opportunity a fit for projects that are innovative and hypothesis-generating, such as identifying potential biological mechanisms, developing or refining diagnostic strategies, piloting interventions, or integrating clinical observations with laboratory, behavioral, or population-based data. The "Clinical Trial Optional" designation means applicants are allowed, but not required, to propose a clinical trial. Teams can submit either non-trial studies (for example, mechanistic work, biomarker discovery, or observational studies) or a carefully designed pilot clinical trial when appropriate, as long as the proposed approach matches the exploratory nature of an R21.

Research topics that align with the announcement include studies on etiology (root causes and contributing mechanisms), prevention strategies (including risk identification and early intervention concepts), improved diagnosis (such as new clinical assessment approaches, validated tools, biomarkers, phenotyping methods, or differential diagnosis frameworks), and therapeutics (pharmacologic, behavioral, procedural, rehabilitative, or other intervention concepts). The multidisciplinary emphasis suggests NIH is looking for applications that bridge areas such as gynecology, pain medicine, neurology, immunology, microbiology, endocrinology, genetics/genomics, psychology/psychiatry, physical therapy, epidemiology, biostatistics, health services research, and patient-centered outcomes research. Projects that better define vulvodynia subtypes, clarify overlapping pain conditions, or explain variability in treatment response would also fit the broader intent because they can move the field toward more precise, personalized care.

The opportunity is categorized as a grant within the health-related federal assistance portfolio and is associated with CFDA numbers 93.313 and 93.865. The posted award ceiling is $200,000, indicating the upper limit NIH expected for the award amount under this specific listing. While the source data does not specify the number of expected awards, it does list an "ExpectedAwards" field without a value, which typically means the number could vary depending on application volume, quality, and available funds.

Eligibility is broad and intentionally inclusive. In addition to common U.S. applicant types like public and private institutions of higher education, state and local governments, independent school districts, special district governments, and nonprofit organizations (including both 501(c)(3) and non-501(c)(3) nonprofits), the FOA explicitly allows applications from for-profit organizations (other than small businesses) and small businesses. It also welcomes participation from Native American tribal governments (federally recognized) and tribal organizations (other than federally recognized tribal governments), as well as public housing authorities and Indian housing authorities. The announcement also highlights additional eligible applicants such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, eligible federal agencies, regional organizations, U.S. territories or possessions, and even non-U.S. entities (foreign organizations). That breadth suggests NIH is aiming to expand the range of institutions and communities contributing to vulvodynia research, which can be important for improving generalizability, addressing disparities, and ensuring diverse patient populations are represented in study designs.

Key administrative details from the listing include the funding opportunity number PA-18-096, a creation date of 2017-11-06, and an original closing date of 2019-05-07. Those dates indicate this specific posting is not current as written, but the summary still captures NIH's stated research priorities and the kinds of projects they were actively encouraging under this FOA.

• The National Institutes of Health in the health, income security and social services sector is offering a public funding opportunity titled "Multidisciplinary Research in Vulvodynia (R21 Clinical Trial Optional)" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.313, 93.865.
• This funding opportunity was created on 2017-11-06.
• Applicants must submit their applications by 2019-05-07. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• Each selected applicant is eligible to receive up to $200,000.00 in funding.
• Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.

Apply for PA 18 096

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: